Congressman Don Beyer, a former long-time member of the House Committee on Science, Space, and Technology and the U.S. Representative for a Northern Virginia congressional district that includes the ...
A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.
Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...
A new computational tool could help researchers identify promising drug combinations for treating cancer, according to a new ...
However, as groundbreaking as these therapies are, they also pose unique challenges for the drug development process, particularly regarding quality assurance (QA). The role of QA is more critical ...
Recently, a joint research team developed a novel quantum-classical computing scheme for designing photochromic ...
The pharmaceutical industry is undergoing a major transformation, placing patients at the forefront of drug development ... throughout the entire drug development process. We are now moving ...
At MD&M West, PIA will give attendees live demonstrations of its assembly technology, including V-RAC. In Booth 5328 in the ...
Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...
Drug-resistant infections occur when pathogens change in ways that render antimicrobial drugs ineffective. As a result, the pathogens survive and continue to spread. When infections are treatable with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback